GSK plc reported £32.7B of revenue over the trailing twelve months, +4.1% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: £32.7B (to FY2025). Net income: £5.72B, trailing twelve months to FY2025. Free cash flow: £6.39B, trailing twelve months to FY2025. Operating margin: 24%, trailing twelve months to FY2025.

GSKGSK plc

Healthcare

$46.51+17% 1Y

$46.51

$38.5152 weeks$60.14

GSK as reported

GSK plc reported £32.7B of revenue over the trailing twelve months, +4.1% on the year before. 10 reported series are charted on this page, each one as filed.

£32.7B

Revenue, trailing twelve months · to FY2025 · +4.1% against the twelve months before

Net income: £5.72B
Net income · +122% year on year · trailing twelve months to FY2025
Free cash flow: £6.39B
Free cash flow · +24% year on year · trailing twelve months to FY2025
Operating margin: 24%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for GSK, trailing twelve months
Series	Latest	Year on year	As of
Revenue	£32.7B	+4.1%	FY2025
Net income	£5.72B	+122%	FY2025
EPS	£1.39	+123%	FY2025
Gross margin	72%	n/a	FY2025
Operating margin	24%	n/a	FY2025
Net margin	17%	n/a	FY2025
ROE	35%	n/a	FY2025
ROA	9.4%	n/a	FY2025
ROIC	20%	n/a	FY2025
Free cash flow	£6.39B	+24%	FY2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.